REFERENCES
- Vaideeswar P: Cavitary pulmonary infarction—a rare cause of spontaneous pneumothorax. J Postgrad Med. 1998;44:99–100.
- Sainz AJ, Navarro LG: Cavitation Pulmonary Noninfectious in An Immunocompromised Host. The Internet Journal of Pulmonary Medicine. 2006;6.
- Shahidi HW: Ventimiglia, Cavitary lung lesion in a patient with congestive heart failure. Chest. 1996;110:276–278.
- Burns KE, Iacono AT: Incidence of clinically unsuspected pulmonary embolism in mechanically ventilated lung transplant recipients. Transplantation. 2003;76:964–948.
- Ahn JM, Im J.G., Ryoo JW, Kim SJ, Do YS, Choi YW, Oh YW, Yeon KM, Han MC: Thoracic manifestations of Behçet syndrome: radiographic and CT findings in nine patients. Radiology. 1995;194:199–203.
- Spearing RL, Pamphilon DH, Prentice AG: Pulmonary aspergillosis in immunosuppressed patients with haematological malignancies. Q J Med. 1986;59:611–625.
- Soubani AO, Chandrasekar PH: The clinical spectrum of pulmonary aspergillosis. Chest. 2002;121:1988–1999.
- Latson LA, Godelman A, Haramati LB: Imaging of pulmonary infarction. Clin Pulm Med. 2010;17:282–289.
- Costello P, Gupta KB: Pulmonary embolism: imaging modalities—V/Q scan, spiral (helical) CT, and MRI. Semin Vasc Med. 2001;1:155–164.
- Zophel K, Bacher-Stier C, Pinkert J, Kropp J: Ventilation/perfusion lung scintigraphy: what is still needed? A review considering technetium-99m-labeled macro-aggregates of albumin. Ann Nucl Med. 2009;23:1–16.
- Child JS, Wolfe JD, Tashkin D, Nakano F: Fatal lung scan in a case of pulmonary hypertension due to obliterative pulmonary vascular disease. Chest. 1975;67:308–310.
- Stein PD, Athanasoulis C, Alavi A, Greenspan RH, Hales CA, Saltzman HA, Vreim CE, Terrin ML, Weg JG:Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation. 1992;85:462–468.
- Kjaergaard B, Kristensen SR, Risom M, Larsson A: A porcine model of massive, totally occlusive, pulmonary embolism. Thromb Res. 2009;124:226–229.
- Frisbie JH: An animal model for venous thrombosis and spontaneous pulmonary embolism. Spinal Cord. 2005;43:635–639.
- Konecny FA: A model of massive pulmonary embolism, development and characterization. J Res Med Sci. 2008:121–134.
- Brown SB, Brown EA, Walker I: The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 2004;5:497–508.
- Sanchez A, Reza M, Blasco JA, Callejo D: Effectiveness, safety, and cost-effectiveness of photodynamic therapy in Barrett's esophagus: a systematic review. Dis Esophagus. 2010;23:633–640.
- O'Connor AE, Gallagher WM, Byrne AT: Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol. 2009;85:1053–1074.
- Augustin AJ, Scholl S, Kirchhof J: Treatment of neovascular age-related macular degeneration: current therapies. Clin Ophthalmol. 2009;3:175–182.
- MacDonald IJ, Dougherty TJ: Basic principles of photodynamic therapy. J Porphy Phthalocyan. 2001;5:105–129.
- Plaetzer K, Krammer B, Berlanda J, Berr F, Kiesslich T: Photophysics and photochemistry of photodynamic therapy: fundamental aspects. Lasers Med Sci. 2009;24:259–268.
- Schmidt R: Photosensitized generation of singlet oxygen. Photochem Photobiol. 2006;82:1161–1177.
- Canti G, De Simone A, Korbelik M: Photodynamic therapy and the immune system in experimental oncology. Photochem Photobiol Sci. 2002;1:79–80.
- Seshadri M, Spernyak JA, Mazurchuk R, Camacho SH, Oseroff AR, Cheney RT, Bellnier DA: Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy. Clin Cancer Res. 2005;11:4241–4250.
- Fingar VH: Vascular effects of photodynamic therapy. J Clin Laser Med Surg. 1996;14:323–328.
- Fingar VH, Wieman TJ, Wiehle SA, Cerrito PB: The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. Cancer Res. 1992;52:4914–4921.
- Wieman TJ, Mang TS, Fingar VH, Hill TG, Reed MW, Corey TS, Nguyen VQ, Render ER Jr: Effect of photodynamic therapy on blood flow in normal and tumor vessels. Surgery. 1988;104:512–517.
- De Lassence A, Fleury-Feith J, Escudier E, Beaune J, Bernaudin JF, Cordonnier C: Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med. 1995;151:157–163.
- Cho JH, Kim JT, Kim L, Lee KH, Ryu JS, Kwak SM, Lee HL: A pulmonary nodule due to pulmonary infarction diagnosed by video-assisted thoracoscopy. Yonsei Med J. 2009;50:591–593.
- Balyasnikova IV, Berestetskaya JV, Visintine DJ, Nesterovitch AB, Adamian L, Danilov SM: Cloning and characterization of a single-chain fragment of monoclonal antibody to ACE suitable for lung endothelial targeting. Microvasc Res. 2010;80:355–364.
- Chrastina A, Valadon P, Massey KA, Schnitzer JE: Lung vascular targeting using antibody to aminopeptidase P: CT-SPECT imaging, biodistribution and pharmacokinetic analysis. J Vasc Res. 2010;47:531–543.
- Oh P, Borgstrom P, Witkiewicz H, Li Y, Borgstrom BJ, Chrastina A, Iwata K, Zinn KR, Baldwin R, Testa JE, Schnitzer JE: Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol. 2007;25:327–337.
- Testa JE, Chrastina A, Oh P, Li Y, Witkiewicz H, Czarny M, Buss T, Schnitzer JE: Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo. Am J Physiol Lung Cell Mol Physiol. 2009;297:L251–L262.
- Valadon P, Darsow B, Buss TN, Czarny M, Griffin NM, Nguyen HN, Oh P, Borgstrom P, Chrastina A, Schnitzer JE: Designed auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo. J Biol Chem. 2010;285:713–722.
- Danilov SM, Gavrilyuk VD, Franke FE, Pauls K, Harshaw DW, McDonald TD, Miletich DJ, Muzykantov VR: Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Am J Physiol Lung Cell Mol Physiol. 2001;280:L1335–L1347.